Savencia SA

Savencia operates with a debt-to-equity ratio of 0.74, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.12, suggesting it has just enough current assets to cover its current liabilities. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if not managed effectively. In terms of profitability, Savencia's return on equity (ROE) is 4.44%, and its return on assets (ROA) is 1.53%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating high returns relative to its equity or total assets. The operating margin, calculated as operating income divided by revenue, is 2.33%, which is a key metric for assessing operational efficiency in the industry. Savencia's revenue is concentrated in a few key segments and geographic regions. The company's primary revenue streams are from cheese and dairy products, with a significant portion of its sales coming from the European market. This concentration could expose the company to regional economic downturns or regulatory changes that affect the dairy industry. Looking at the company's growth trajectory, Savencia's revenue for the latest fiscal year is EUR 6.96 billion. While the company has a history of stable revenue, the outlook for the next fiscal year is not explicitly provided. The company's capital expenditure for the latest period was EUR -254.41 million, indicating a reduction in investment in physical assets, which could affect long-term growth. The risk assessment for Savencia highlights a medium liquidity risk and a low dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution risk is low, as the number of shares outstanding has not changed significantly between basic and diluted shares. Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's analyst estimates show a mean price target of EUR 79.00, with a mean recommendation of 2.00, indicating a neutral stance from analysts. The lack of strong buy recommendations suggests that analysts do not see significant upside potential in the near term.